Your browser doesn't support javascript.
A third vaccine dose substantially improves humoral and cellular SARS-CoV-2 immunity in renal transplant recipients with primary humoral nonresponse.
Westhoff, Timm H; Seibert, Felix S; Anft, Moritz; Blazquez-Navarro, Arturo; Skrzypczyk, Sarah; Zgoura, Panagiota; Meister, Toni L; Pfaender, Stephanie; Stumpf, Julian; Hugo, Christian; Viebahn, Richard; Roch, Toralf; Stervbo, Ulrik; Babel, Nina.
  • Westhoff TH; Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Herne, Germany. Electronic address: timm.westhoff@elisabethgruppe.de.
  • Seibert FS; Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Herne, Germany.
  • Anft M; Center for Translational Medicine and Immune Diagnostics Laboratory, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Herne, Germany.
  • Blazquez-Navarro A; Center for Translational Medicine and Immune Diagnostics Laboratory, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Herne, Germany; Berlin Center for Advanced Therapies, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität, Berlin, Humboldt-Universität
  • Skrzypczyk S; Center for Translational Medicine and Immune Diagnostics Laboratory, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Herne, Germany.
  • Zgoura P; Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Herne, Germany.
  • Meister TL; Department of Molecular and Medical Virology, Ruhr-University Bochum, Bochum, Germany.
  • Pfaender S; Department of Molecular and Medical Virology, Ruhr-University Bochum, Bochum, Germany.
  • Stumpf J; Medizinische Klinik und Poliklinik III, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Hugo C; Medizinische Klinik und Poliklinik III, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Viebahn R; Department of Surgery, University Hospital Knappschaftskrankenhaus Bochum, Ruhr-University Bochum, Bochum, Germany.
  • Roch T; Center for Translational Medicine and Immune Diagnostics Laboratory, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Herne, Germany; Berlin Center for Advanced Therapies, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität, Berlin, Humboldt-Universität
  • Stervbo U; Center for Translational Medicine and Immune Diagnostics Laboratory, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Herne, Germany.
  • Babel N; Center for Translational Medicine and Immune Diagnostics Laboratory, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Herne, Germany; Berlin Center for Advanced Therapies, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität, Berlin, Humboldt-Universität
Kidney Int ; 100(5): 1135-1136, 2021 11.
Article in English | MEDLINE | ID: covidwho-1428231
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Kidney Transplantation / Transplant Recipients / COVID-19 Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Kidney Int Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Kidney Transplantation / Transplant Recipients / COVID-19 Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Kidney Int Year: 2021 Document Type: Article